Comparison of efficacy and complications between radiofrequency ablation and repeat surgery in the treatment of locally recurrent thyroid cancers: a single-center propensity score matching study

References

• Lin Y, Li T, Liang J, et al. Predictive value of preablation stimulated thyroglobulin and thyroglobulin/thyroid-stimulating hormone ratio in differentiated thyroid cancer. Clin Nucl Med. 2011;36:1102–1105.
   PubMed Web of Science ®Google Scholar
• Morris LG, Sikora AG, Tosteson TD, et al. The increasing incidence of thyroid cancer: the influence of access to care. Thyroid. 2013;23:885–891.
   PubMed Web of Science ®Google Scholar
• Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97:418–428.
   PubMed Web of Science ®Google Scholar
• Baek JH, Kim YS, Sung JY, et al. Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation. Am J Roentgenol. 2011;197:W331–W336.
   PubMed Web of Science ®Google Scholar
• Kim JH, Baek JH, Lim HK, et al. 2017 Thyroid Radiofrequency Ablation Guideline: Korean Society of Thyroid Radiology. Korean J Radiol. 2018;19:632–655.
   PubMed Web of Science ®Google Scholar
• Gilliland FD, Hunt WC, Morris DM, et al. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer. 1997;79:564–573.
   PubMed Web of Science ®Google Scholar
• Sippel RS, Chen H. Controversies in the surgical management of newly diagnosed and recurrent/residual thyroid cancer. Thyroid. 2009;19:1373–1380.
   PubMed Web of Science ®Google Scholar
• Samaan NA, Schultz PN, Hickey RC, et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metabol. 1992;75:714–720.
   PubMed Web of Science ®Google Scholar
• American Thyroid Association Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–1214.
   PubMed Web of Science ®Google Scholar
• Mauri G, Cova L, Ierace T, et al. Treatment of metastatic lymph nodes in the neck from papillary thyroid carcinoma with percutaneous laser ablation. Cardiovasc Intervent Radiol. 2016;39:1023–1030.
   PubMed Web of Science ®Google Scholar
• Mauri G, Cova L, Tondolo T, et al. Percutaneous laser ablation of metastatic lymph nodes in the neck from papillary thyroid carcinoma: preliminary results. J Clin Endocrinol Metabol. 2013;98:E1203–E1207.
   PubMed Web of Science ®Google Scholar
• Teng D, Ding L, Wang Y, et al. Safety and efficiency of ultrasound-guided low power microwave ablation in the treatment of cervical metastatic lymph node from papillary thyroid carcinoma: a mean of 32 months follow-up study. Endocrine. 2018;62:648–654.
   PubMed Web of Science ®Google Scholar
• Suh CH, Baek JH, Choi YJ, et al. Efficacy and safety of radiofrequency and ethanol ablation for treating locally recurrent thyroid cancer: a systematic review and meta-analysis. Thyroid. 2016;26:420–428.
   PubMed Web of Science ®Google Scholar
• Holmer C, Lehmann KS, Knappe V, et al. Bipolar radiofrequency ablation for nodular thyroid disease–ex vivo and in vivo evaluation of a dose-response relationship. J Surg Res. 2011;169:234–240.
   PubMed Web of Science ®Google Scholar
• Jeong WK, Baek JH, Rhim H, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol. 2008;18:1244–1250.
   PubMed Web of Science ®Google Scholar
• Mauri G, Cova L, Monaco CG, et al. Benign thyroid nodules treatment using percutaneous laser ablation (PLA) and radiofrequency ablation (RFA). Int J Hypertherm. 2016;15:1–5.
   Google Scholar
• Mainini AP, Monaco C, Pescatori LC, et al. Image-guided thermal ablation of benign thyroid nodules. J Ultrasound. 2017;20:11–22.
   PubMed Web of Science ®Google Scholar
• Lim HK, Lee JH, Ha EJ, et al. Radiofrequency ablation of benign non-functioning thyroid nodules: 4-year follow-up results for 111 patients. Eur Radiol. 2013;23:1044–1049.
   PubMed Web of Science ®Google Scholar
• Li XL, Xu HX, Lu F, et al. Treatment efficacy and safety of ultrasound-guided percutaneous bipolar radiofrequency ablation for benign thyroid nodules. BJR. 2016;89:20150858.
   Google Scholar
• Kim JH, Baek JH, Sung JY, et al. Radiofrequency ablation of low-risk small papillary thyroidcarcinoma: preliminary results for patients ineligible for surgery. Int J Hyperthermia. 2017;33:212–219.
   PubMed Web of Science ®Google Scholar
• Wang L, Ge M, Xu D, et al. Ultrasonography-guided percutaneous radiofrequency ablation for cervical lymph node metastasis from thyroid carcinoma. J Can Res Ther. 2014;10:C144–C149.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Jung SL, Kim BS, et al. Radiofrequency ablation to treat loco-regional recurrence of well-differentiated thyroid carcinoma. Korean J Radiol. 2014;15:817–826.
   PubMed Web of Science ®Google Scholar
• Guenette JP, Monchik JM, Dupuy DE. Image-guided ablation of postsurgical locoregional recurrence of biopsy-proven well-differentiated thyroid carcinoma. J Vasc Intervent Radiol. 2013;24:672–679.
   PubMed Web of Science ®Google Scholar
• Kim JH, Yoo WS, Park YJ, et al. Efficacy and safety of radiofrequency ablation for treatment of locally recurrent thyroid cancers smaller than 2 cm. Radiology. 2015;276:909–918.
   PubMed Web of Science ®Google Scholar
• Monchik JM, Donatini G, Iannuccilli J, et al. Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg. 2006;244:296–304.
   PubMed Web of Science ®Google Scholar
• Baek JH, Lee JH, Sung JY, et al. Complications encountered in the treatment of benign thyroid nodules with US-guided radiofrequency ablation: a multicenter study. Radiology. 2012;262:335–342.
   PubMed Web of Science ®Google Scholar
• Na DG, Lee JH, Jung SL, et al. Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations. Korean J Radiol. 2012;13:117–125.
   PubMed Web of Science ®Google Scholar
• Shin JE, Baek JH, Lee JH. Radiofrequency and ethanol ablation for the treatment of recurrent thyroid cancers: current status and challenges. Curr Opin Oncol. 2013;25:14–19.
   PubMed Web of Science ®Google Scholar
• Kim C, Lee JH, Choi YJ, et al. Complications encountered in ultrasonography-guided radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers. Eur Radiol. 2017;27:3128–3137.
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Charboneau JW, Dodd GD, 3rd, et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology. 2003;228:335–345.
   PubMed Web of Science ®Google Scholar
• Ahmed M. Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update: supplement to the consensus document. J Vasc Intervent Radiol. 2014;25:1706–1708.
   PubMed Web of Science ®Google Scholar
• Chung SR, Suh CH, Baek JH, et al. Safety of radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: a systematic review and meta-analysis. Int J Hyperthermia. 2017;33:920–930.
   PubMed Web of Science ®Google Scholar
• Park KW, Shin JH, Han BK, et al. Inoperable symptomatic recurrent thyroid cancers: preliminary result of radiofrequency ablation. Ann Surg Oncol. 2011;18:2564–2568.
   PubMed Web of Science ®Google Scholar
• Kim MK, Mandel SH, Baloch Z, et al. Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg. 2004;130:1214–1216.
   PubMedGoogle Scholar
• Dupuy DE, Monchik JM, Decrea C, et al. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery. 2001;130:971–977.
   PubMed Web of Science ®Google Scholar
• Lim HK, Baek JH, Lee JH, et al. Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer. Eur Radiol. 2015;25:163–170.
   PubMed Web of Science ®Google Scholar
• Mauri G, Nicosia L, Della Vigna P, et al. Percutaneous laser ablation for benign and malignant thyroid diseases. Ultrasonography. 2019;38(1):25–36.
   PubMed Web of Science ®Google Scholar
• Valcavi R, Tsamatropoulos P. Health-related quality of life after percutaneous radiofrequency ablation of cold, solid, benign thyroid nodules: a 2-year follow-up study in 40 patients. Endocr Practice. 2015;21:887–896.
   PubMed Web of Science ®Google Scholar
• Yue WW, Wang SR, Li XL, et al. Quality of life and cost-effectiveness of radiofrequency ablation versus open surgery for benign thyroid nodules: a retrospective cohort study. Scientif Reports. 2016;6:37838.
   PubMed Web of Science ®Google Scholar